Study guide
1.1 Cardiovascular Physiology, Hemodynamics & Ischemic Heart Disease
NBCRNA CRNA Certified Registered Nurse Anesthetist NCE
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Cardiovascular, Respiratory & CNS Physiology & Pathophysiology
1.1 Cardiovascular Physiology, Hemodynamics & Ischemic Heart Disease 1.2 Respiratory Physiology, Lung Volumes & Chronic Pulmonary Pathophysiology 1.3 Central & Autonomic Nervous System Physiology & Neurological Disorders
2 Chapter 2: Hepatorenal, Endocrine & Hematologic/Immune Systems
2.1 Renal Physiology, Glomerular Filtration & Acid-Base Balance 2.2 Hepatic Physiology, Drug Clearance & Gastrointestinal Considerations 2.3 Endocrine Disorders, Hematology, Coagulation & Immune Mechanisms
3 Chapter 3: Anesthetic Pharmacology: Inhalation Agents, Intravenous Anesthetics & Sedatives
3.1 Inhalation Anesthetics: Uptake, Distribution, Blood/Gas Solubility & MAC 3.2 Intravenous Hypnotics: Propofol, Etomidate, Ketamine & Barbiturates 3.3 Opioid Agonists/Antagonists, Benzodiazepines & Reversal Pharmacology
4 Chapter 4: Anesthetic Pharmacology: Neuromuscular Blockers, Local Anesthetics & Physics
4.1 Neuromuscular Blocking Agents & Reversal: Anticholinesterases vs Sugammadex 4.2 Local Anesthetics: Mechanism, Potency, Toxicity (LAST) & Vasoconstrictors 4.3 Applied Physics, Gas Laws, Fluid Dynamics & Anesthesia Mathematics
5 Chapter 5: Anesthesia Delivery Systems & Gas Supplies
5.1 Medical Gas Supply Systems, Cylinders, Regulators & Safety Index Systems (PISS/DISS) 5.2 Anesthesia Machine High, Intermediate & Low Pressure Systems & Failsafe Mechanisms 5.3 Vaporizer Technology: Variable-Bypass vs Desflurane Vaporizers & Machine Checkout
6 Chapter 6: Breathing Circuits, CO2 Absorption & Ventilators
6.1 Breathing Circuits: Circle System, Mapleson Classifications & Dead Space 6.2 Carbon Dioxide Absorption: Soda Lime Chemistry, Desiccation, Carbon Monoxide & Compound A 6.3 Anesthesia Ventilators, Pressure/Volume Modes, APL Valves & Waste Gas Scavenging
7 Chapter 7: Airway Equipment & Advanced Airway Instrumentation
7.1 Face Masks, Supraglottic Airways (LMA Types) & Endotracheal Tubes 7.2 Direct Laryngoscopy (Mac/Miller) & Video Laryngoscopy 7.3 Fiberoptic Intubation, Bronchial Blockers, Double-Lumen Tubes & Surgical Airways
8 Chapter 8: Patient Monitoring, Hemodynamics & Electrosurgical Safety
8.1 Noninvasive Monitoring: Pulse Oximetry, Capnography Waveforms & Temperature 8.2 Invasive Hemodynamics: Arterial Lines, CVP & Pulmonary Artery Catheters 8.3 Neuromuscular Monitoring (TOF/PTC), Depth of Anesthesia (EEG/BIS) & Electrical Safety
9 Chapter 9: Preoperative Assessment, Risk Stratification & Preparation
9.1 Preoperative History, Physical Examination & ASA Physical Status Classification 9.2 Cardiac & Pulmonary Risk Stratification, Diagnostic Testing & Optimization 9.3 Preoperative Fasting Guidelines, Aspiration Prophylaxis & Premedication
10 Chapter 10: Fluid Management, Blood Component Therapy & Coagulation Monitoring
10.1 Crystalloids vs Colloids, Maintenance & Deficit Calculations 10.2 Blood Component Therapy, Transfusion Triggers & Massive Transfusion Protocols 10.3 Point-of-Care Coagulation: TEG, ROTEM & Perioperative Coagulopathies
11 Chapter 11: Airway Management Strategies & Difficult Airway Algorithms
11.1 Difficult Airway Assessment: Mallampati, Cormack-Lehane & Airway Predictors 11.2 ASA Difficult Airway Algorithm: Anticipated vs Unanticipated Difficult Airway 11.3 "Cannot Intubate, Cannot Oxygenate" (CICO) & Emergency Front-of-Neck Access (eFONA)
12 Chapter 12: General Anesthesia: Induction, Maintenance, Emergence & TIVA
12.1 Rapid Sequence Induction (RSI), Cricoid Pressure & Intubation Protocols 12.2 Balanced Anesthesia vs Total Intravenous Anesthesia (TIVA) Principles 12.3 Emergence, Extubation Criteria, Deep vs Awake Extubation & Laryngospasm
13 Chapter 13: Regional Anesthesia: Neuraxial Blocks
13.1 Spinal Anesthesia: Anatomy, Physiology, High Spinal & Complications 13.2 Epidural & Combined Spinal-Epidural (CSE) Techniques & PDPH 13.3 Neuraxial Anticoagulation Guidelines (ASRA) & Epidural Hematoma
14 Chapter 14: Regional Anesthesia: Peripheral Nerve Blocks & Ultrasound Guidance
14.1 Upper Extremity Peripheral Nerve Blocks: Interscalene, Supraclavicular, Axillary 14.2 Lower Extremity & Truncal Blocks: Femoral, Sciatic, TAP & ESP Blocks 14.3 Ultrasound Physics, Needle Visualization & LAST Rescue Protocols
15 Chapter 15: Perioperative Safety, Positioning, PACU, Ethics & Professional Practice
15.1 Surgical Positioning Complications: Nerve Injuries & Physiologic Changes 15.2 PACU Discharge Criteria, PONV Management, Hypoxemia & Emergence Delirium 15.3 Malignant Hyperthermia Protocol & Operating Room Crisis Management 15.4 CRNA Ethics, Informed Consent, Scope of Practice & Wellness Initiatives
16 Chapter 16: Obstetric & Gynecologic Anesthesia
16.1 Maternal Physiology & Pharmacokinetics Across Trimesters 16.2 Labor Analgesia & Anesthesia for Cesarean Delivery 16.3 Obstetric Emergencies: Preeclampsia, Hemorrhage & Amniotic Fluid Embolism 16.4 Nonobstetric Surgery in the Pregnant Patient
17 Chapter 17: Pediatric Anesthesia
17.1 Pediatric Anatomy, Physiology, Airway & Developmental Pharmacology 17.2 Pediatric Induction, Maintenance, Fluids & Emergence Agitation 17.3 Pediatric Respiratory Emergencies: Croup, Epiglottitis & Laryngospasm
18 Chapter 18: Geriatric, Bariatric & Ambulatory Anesthesia
18.1 Geriatric Physiology, Pharmacodynamics & Postoperative Delirium/POCD 18.2 Bariatric Anesthesia: Obesity Hypoventilation, OSA & Dosing Adjustments 18.3 Ambulatory Surgery Selection Criteria & ERAS Protocols
19 Chapter 19: Cardiac, Vascular & Thoracic Anesthesia
19.1 Valvular Heart Disease, CAD & Cardiopulmonary Bypass Management 19.2 Vascular Anesthesia: Carotid Endarterectomy & Aortic Cross-Clamping 19.3 Thoracic Anesthesia: One-Lung Ventilation & Hypoxic Pulmonary Vasoconstriction
20 Chapter 20: Neurosurgical, Intra-Abdominal, Extrathoracic, Head/Neck & Trauma Anesthesia
20.1 Neurosurgical Anesthesia: ICP Dynamics, Craniotomy & Venous Air Embolism 20.2 Intra-Abdominal, Laparoscopy & Endocrine Tumor Anesthesia (Pheochromocytoma, Carcinoid) 20.3 ENT/Shared Airway, Extrathoracic Procedures & Trauma/Burn Resuscitation
21 Chapter 21: Neurologic, Gastrointestinal & Substance-Related Pathophysiology and Pharmacology
21.1 Neurodegenerative & Demyelinating Disease and Antiparkinsonian Pharmacology 21.2 Gastrointestinal & Exocrine Pancreatic Disorders: Esophageal, Gastric, Pancreatitis & Malabsorption 21.3 Cannabinoids, Herbal Remedies & Dietary Supplements
22 Chapter 22: Imaging Safety, Patient Warming & Infusion Technology
22.1 Fluoroscopy, Radiography & Radiation Safety in Anesthetizing Locations 22.2 Patient Warming Equipment & Rapid Infusion Devices
23 Chapter 23: Pain Medicine: Theory, Chronic Pain & Interventional Procedures
23.1 Pain Theory: Nociception, Sensitization & Chronic Pain Pathophysiology 23.2 Chronic Pain Management, Medication-Assisted Therapy & the Opioid-Tolerant Patient 23.3 Interventional Pain Procedures & Anesthesia for Pain Management Cases
24 Chapter 24: Professional Practice: Research Ethics, Error Disclosure & Provider Infection Control
24.1 Research Ethics, IRB Oversight & Protection of Human Subjects 24.2 Disclosure of Errors and Injuries, Adverse Event Reporting & Just Culture 24.3 Provider Infection Control: PPE, Air Handling & Occupational Exposure
25 Chapter 25: Neurosurgical Subspecialty Procedures
25.1 Cerebral Aneurysm Clipping, AVM Resection & Subarachnoid Hemorrhage 25.2 Transsphenoidal Hypophysectomy & Pituitary Surgery 25.3 Stereotactic Procedures, Deep Brain Stimulation & Awake Craniotomy 25.4 CSF Diversion, Burr Holes, Ventriculoperitoneal Shunts & Decompressive Craniectomy
26 Chapter 26: Head, Neck, Nasal, Dental & Ophthalmic Anesthesia
26.1 Nasal & Sinus Surgery, Nasotracheal Intubation & Craniofacial Procedures 26.2 Dental, Orthodontic, Oral-Maxillofacial & Ophthalmic Anesthesia 26.3 Neck Tumors, Radical Neck Dissection, Lymph Node Biopsy & Thyroid/Parathyroid Surgery
27 Chapter 27: Orthopedic & Extremity Anesthesia
27.1 Total Joint Arthroplasty, Bone Cement Implantation Syndrome & Tourniquet Physiology 27.2 Closed Reduction, Hand and Foot Procedures & Intravenous Regional (Bier) Block
28 Chapter 28: Non-Operating-Room Anesthesia: Interventional, Imaging & Radiation Therapy
28.1 Interventional and Neurointerventional Radiology Anesthesia 28.2 Radiation Therapy, Diagnostic Imaging & MRI-Suite Anesthesia
29 Chapter 29: Special Populations: Substance Use Disorder, Immunocompromised & Oncology Patients
29.1 Acute Intoxication, Withdrawal Syndromes & Perioperative Complications 29.2 Anesthesia for the Immunocompromised & Oncology Patient
1.1 Cardiovascular Physiology, Hemodynamics & Ischemic Heart Disease
Key Takeaways Explain This Topic AI
Cardiac output equals Heart Rate multiplied by Stroke Volume (normal CO: 4-8 L/min; Cardiac Index: 2.5-4.0 L/min/m²), with stroke volume determined by preload, afterload, and contractility.
Left ventricular coronary perfusion pressure equals Diastolic Blood Pressure minus Left Ventricular End-Diastolic Pressure (CPP = DBP - LVEDP); 80-85% of LV myocardial perfusion occurs during diastole.
Myocardial oxygen consumption (MVO₂) is primarily driven by heart rate, followed by wall tension (afterload) and contractility; tachycardia is the most detrimental hemodynamic state in coronary artery disease.
Systemic vascular resistance is calculated as SVR = [(MAP - CVP) / CO] × 80 (normal: 800-1200 dynes·s·cm⁻⁵); Pulmonary vascular resistance is PVR = [(MPAP - PAOP) / CO] × 80 (normal: 100-250 dynes·s·cm⁻⁵).
Coronary steal occurs when potent arteriolar vasodilators (adenosine, dipyridamole) dilate resistance vessels in non-ischemic zones, diverting blood flow away from maximally dilated, stenotic ischemic subendocardial beds.
Last updated: August 2026
1.1 Cardiovascular Physiology, Hemodynamics & Ischemic Heart Disease
A mastery of cardiovascular physiology, intracardiac pressure dynamics, and coronary perfusion mechanics is essential for perioperative hemodynamic management during general, regional, and monitored anesthesia care. This section provides an in-depth review of cardiac performance determinants, vascular resistance calculations, coronary physiology, and anesthetic strategies for ischemic heart disease.
1. Determinants of Cardiac Output & The Cardiac Cycle
Cardiac output ( C O CO CO ) is the volume of blood pumped by the heart per unit time, defined as: C O = H R × S V CO = HR \times SV CO = H R × S V
Normal Resting Cardiac Output: 4.0 − 8.0 L/min 4.0 - 8.0 \text{ L/min} 4.0 − 8.0 L/min
Cardiac Index ( C I = C O / B S A CI = CO / BSA C I = CO / BS A ): 2.5 − 4.0 L/min/m 2 2.5 - 4.0 \text{ L/min/m}^2 2.5 − 4.0 L/min/m 2
Normal Stroke Volume ( S V SV S V ): 60 − 100 mL/beat 60 - 100 \text{ mL/beat} 60 − 100 mL/beat
Stroke volume represents the volume ejected per contraction ( S V = E D V − E S V SV = EDV - ESV S V = E D V − ES V ) and is governed by three interrelated mechanical variables: preload , afterload , and contractility . +-------------------------------------------------------------------------+
- | DETERMINANTS OF STROKE VOLUME |
- +-------------------+-----------------------------+-----------------------+
- | Preload | Afterload | Contractility |
- | (End-Diastolic | (Ventricular Wall Stress | (Inotropy / Chemical |
- | Fiber Length) | During Systolic Ejection) | State of Myocardium) |
- +-------------------+-----------------------------+-----------------------+
- The Frank-Starling Mechanism
The Frank-Starling law states that the force of myocardial contraction is directly proportional to the initial length of the cardiac muscle fibers (sarcomere stretch).
Optimal Sarcomere Length: Approximately 2.2 μ m 2.2 \,\mu\text{m} 2.2 μ m , allowing maximal overlap between actin and myosin cross-bridges.
Physiologic Principle: Increased end-diastolic volume (EDV) increases myocardial stretch, resulting in a more forceful contraction and increased stroke volume up to a physiologic limit.
Curve Shifts: Inotropic agents (epinephrine, calcium, dopamine) shift the Starling curve upward and to the left (greater SV at lower filling pressures). Volatile anesthetics, propofol, beta-blockers, acidosis, hypercapnia, and myocardial ischemia shift the curve downward and to the right .
- 2. Preload, Afterload & Ventricular Wall Stress
- Preload Dynamics & Ventricular Compliance
Preload is the myocardial wall tension at the end of diastole, clinically approximated by end-diastolic volume (EDV) or end-diastolic pressure (EDP).
Right Ventricular Preload: Central Venous Pressure (CVP: 2 − 6 mmHg 2 - 6 \text{ mmHg} 2 − 6 mmHg ).
Left Ventricular Preload: Pulmonary Artery Occlusion Pressure (PAOP/PCWP: 6 − 12 mmHg 6 - 12 \text{ mmHg} 6 − 12 mmHg ) or Left Ventricular End-Diastolic Area (LVEDA via transesophageal echocardiography).
Ventricular Compliance ( Δ V / Δ P \Delta V / \Delta P Δ V /Δ P ): In a non-compliant or hypertrophied ventricle (e.g., severe aortic stenosis, chronic hypertension, acute myocardial ischemia), small increases in end-diastolic volume produce steep, disproportionate spikes in LVEDP. Conversely, a dilated, compliant ventricle accommodates large volume increases with minimal pressure elevation.
Afterload & Laplace's Law
Afterload represents the tension or stress in the ventricular wall during systolic ejection. Laplace's Law defines myocardial wall stress ( σ \sigma σ ) as: σ = P × r 2 h \sigma = \frac{P \times r}{2h} σ = 2 h P × r
Where:
P = Intraventricular systolic pressure P = \text{Intraventricular systolic pressure} P = Intraventricular systolic pressure
r = Ventricular internal radius (chamber dimension) r = \text{Ventricular internal radius (chamber dimension)} r = Ventricular internal radius (chamber dimension)
h = Ventricular wall thickness h = \text{Ventricular wall thickness} h = Ventricular wall thickness
Clinical Applications of Laplace's Law:
Concentric Hypertrophy (Pressure Overload, e.g., Aortic Stenosis, HTN): Parallel replication of sarcomeres increases wall thickness ( h h h ), which normalizes wall stress ( σ \sigma σ ) in the face of elevated intracavitary pressure ( P P P ).
Eccentric Hypertrophy (Volume Overload, e.g., Aortic/Mitral Regurgitation): Series replication of sarcomeres dilates the chamber radius ( r r r ), which significantly increases wall stress ( σ \sigma σ ) and accelerates myocardial oxygen consumption.
Hemodynamic Formulas & Normal Values
Hemodynamic Parameter Mathematical Formula Standard Normal Range Units
Mean Arterial Pressure (MAP) S B P + 2 ( D B P ) 3 = D B P + P P 3 \frac{SBP + 2(DBP)}{3} = DBP + \frac{PP}{3} 3 SBP + 2 ( D BP ) = D BP + 3 PP 70 − 105 70 - 105 70 − 105 mmHg \text{mmHg} mmHg
Systemic Vascular Resistance (SVR) M A P − C V P C O × 80 \frac{MAP - CVP}{CO} \times 80 CO M A P − C V P × 80 800 − 1200 800 - 1200 800 − 1200 dynes ⋅ s ⋅ cm − 5 \text{dynes}\cdot\text{s}\cdot\text{cm}^{-5} dynes ⋅ s ⋅ cm − 5
SVR Index (SVRI) M A P − C V P C I × 80 \frac{MAP - CVP}{CI} \times 80 C I M A P − C V P × 80 1600 − 2400 1600 - 2400 1600 − 2400 dynes ⋅ s ⋅ cm − 5 ⋅ m 2 \text{dynes}\cdot\text{s}\cdot\text{cm}^{-5}\cdot\text{m}^2 dynes ⋅ s ⋅ cm − 5 ⋅ m 2
Pulmonary Vascular Resistance (PVR) M P A P − P A O P C O × 80 \frac{MPAP - PAOP}{CO} \times 80 CO MP A P − P A OP × 80 100 − 250 100 - 250 100 − 250 dynes ⋅ s ⋅ cm − 5 \text{dynes}\cdot\text{s}\cdot\text{cm}^{-5} dynes ⋅ s ⋅ cm − 5
PVR Index (PVRI) M P A P − P A O P C I × 80 \frac{MPAP - PAOP}{CI} \times 80 C I MP A P − P A OP × 80 200 − 450 200 - 450 200 − 450 dynes ⋅ s ⋅ cm − 5 ⋅ m 2 \text{dynes}\cdot\text{s}\cdot\text{cm}^{-5}\cdot\text{m}^2 dynes ⋅ s ⋅ cm − 5 ⋅ m 2
Left Ventricular Stroke Work Index S V I × ( M A P − P A O P ) × 0.0136 SVI \times (MAP - PAOP) \times 0.0136 S V I × ( M A P − P A OP ) × 0.0136 45 − 60 45 - 60 45 − 60 g ⋅ m/m 2 / beat \text{g}\cdot\text{m/m}^2/\text{beat} g ⋅ m/m 2 / beat
- 3. Coronary Physiology & Perfusion Dynamics
- Coronary Blood Flow (CBF)
Resting coronary blood flow is approximately 225 − 250 mL/min 225 - 250 \text{ mL/min} 225 − 250 mL/min ( 4 − 5 % 4 - 5\% 4 − 5% of total cardiac output), or 75 − 80 mL / 100 g / min 75 - 80 \text{ mL}/100\text{g}/\text{min} 75 − 80 mL /100 g / min .
Resting myocardial oxygen consumption ( M V O 2 MVO_2 M V O 2 ) is 8 − 10 mL O 2 / 100 g / min 8 - 10 \text{ mL } O_2/100\text{g}/\text{min} 8 − 10 mL O 2 /100 g / min .
Oxygen Extraction Ratio: The myocardium has the highest basal oxygen extraction of any organ in the body ( 65 − 75 % 65 - 75\% 65 − 75% , coronary sinus S v O 2 ≈ 30 % SvO_2 \approx 30\% S v O 2 ≈ 30% , P v O 2 ≈ 20 mmHg PvO_2 \approx 20 \text{ mmHg} P v O 2 ≈ 20 mmHg ). Because basal extraction is near-maximal, the heart cannot compensate for increased metabolic demand by extracting more oxygen ; increased demand must be met almost entirely by an increase in coronary blood flow .
Coronary Perfusion Pressure (CPP) C P P L V = D B P − L V E D P CPP_{LV} = DBP - LVEDP CP P L V = D BP − L V E D P Aortic Root Pressure (Diastolic BP)
- |
- v
- [Coronary Vascular Bed]
- ^
- |
- Left Ventricular Cavity Pressure (LVEDP)
Left Ventricle Perfusion Timing: During systole, high intramyocardial tissue pressure exceeds aortic systolic pressure, compressing intramural vessels and halting flow. Consequently, 80 − 85 % 80 - 85\% 80 − 85% of left ventricular coronary perfusion occurs during diastole .
Right Ventricle Perfusion Timing: RV peak systolic pressure ( 25 mmHg 25 \text{ mmHg} 25 mmHg ) is significantly lower than systemic systolic pressure ( 120 mmHg 120 \text{ mmHg} 120 mmHg ). Therefore, the RV is perfused continuously during both systole and diastole ( C P P R V = M A P − C V P CPP_{RV} = MAP - CVP CP P R V = M A P − C V P ).
Coronary Autoregulation: Maintains stable CBF across perfusion pressures of 60 − 140 mmHg 60 - 140 \text{ mmHg} 60 − 140 mmHg . Flow is primarily regulated by local metabolic byproducts (adenosine, nitric oxide, prostaglandins, interstitial H + H^+ H + , K + K^+ K + , C O 2 CO_2 C O 2 ).
Determinants of Myocardial Oxygen Balance +------------------------------------+-------------------------------------+
- | MYOCARDIAL OXYGEN SUPPLY | MYOCARDIAL OXYGEN DEMAND |
- +------------------------------------+-------------------------------------+
- | 1. Diastolic Blood Pressure (DBP) | 1. Heart Rate (MOST CRITICAL) |
- | 2. Diastolic Perfusion Time (HR) | 2. Afterload / Systolic Wall Stress |
- | 3. Low LVEDP (reduced backpressure)| 3. Myocardial Contractility |
- | 4. Arterial Oxygen Content (CaO₂) | 4. Preload / End-Diastolic Radius |
- | 5. Coronary Vascular Patency | |
- +------------------------------------+-------------------------------------+
NCE Clinical Pearl — Heart Rate is King: Tachycardia exerts a devastating two-fold penalty on myocardial oxygen balance:
It exponentially shortens diastolic filling time, drastically reducing coronary oxygen supply .
It directly increases the number of contractions per minute, dramatically increasing oxygen demand .
- 4. Ischemic Heart Disease (IHD) & Coronary Pathophysiology
- Mechanisms of Ischemia: Flow-Limiting Stenosis & Coronary Steal
Critical Stenosis: A reduction in luminal diameter of ≥ 70 % \ge 70\% ≥ 70% (or ≥ 50 % \ge 50\% ≥ 50% of the Left Main coronary artery) limits maximal coronary flow reserve during stress.
Coronary Steal Syndrome: Occurs in the presence of localized coronary artery stenosis with collateral vessels supplying an ischemic region. When a potent coronary arteriolar vasodilator (e.g., adenosine, dipyridamole, high-dose isoflurane) is administered, resistance vessels in the non-ischemic myocardium dilate widely, lowering local vascular resistance. Because the vessels in the ischemic bed are already maximally dilated by endogenous metabolites, blood is diverted away from the ischemic subendocardium and toward the non-ischemic zone.
Hemodynamic Goals for Patients with Coronary Artery Disease
Parameter Hemodynamic Target Clinical Rationale & Anesthetic Strategy
Heart Rate Slow-Normal ( 50 − 70 bpm 50 - 70 \text{ bpm} 50 − 70 bpm ) Maximizes diastolic time for LV filling and perfusion; minimizes M V O 2 MVO_2 M V O 2 . Treat tachycardia aggressively with beta-1 blockers (esmolol, metoprolol).
Blood Pressure Normal to High-Normal MAP / DBP Maintains driving pressure for coronary blood flow ( C P P = D B P − L V E D P CPP = DBP - LVEDP CPP = D BP − L V E D P ). Treat hypotension with phenylephrine (preserves DBP without beta-induced tachycardia).
Preload Normal (Avoid Volume Overload) Adequate filling maintains stroke volume, but excess preload elevates LVEDP, compressing subendocardial vessels and reducing CPP.
Afterload Normal to Slightly Elevated Adequate afterload maintains DBP and coronary perfusion. Avoid severe afterload spikes which increase systolic wall stress.
Contractility Normal / Mildly Depressed Excessive contractility increases M V O 2 MVO_2 M V O 2 . Avoid pure beta-agonists unless inotropes are required for cardiogenic shock.
Rhythm Sinus Rhythm Coordinated atrial systole ("atrial kick") contributes 20 − 30 % 20 - 30\% 20 − 30% of ventricular end-diastolic volume in non-compliant ventricles.
NCE Exam Trap — Phenylephrine vs. Ephedrine in Severe CAD: In a hypotensive CAD patient with baseline tachycardia ( H R = 95 bpm HR = 95 \text{ bpm} H R = 95 bpm ), Phenylephrine (pure α 1 \alpha_1 α 1 -agonist) is preferred over Ephedrine. Phenylephrine raises SVR and DBP (improving C P P CPP CPP ), and induces a reflex vagal reduction in heart rate (prolonging diastole and lowering M V O 2 MVO_2 M V O 2 ). Ephedrine increases heart rate and contractility via β 1 \beta_1 β 1 stimulation, exacerbating myocardial ischemia.